Does Kawasaki disease cause vomiting?

Written by Li Jiao Yan
Neonatology
Updated on September 03, 2024
00:00
00:00

Kawasaki disease is a disease with no clear etiology, commonly seen in infants and toddlers, with eighty percent of cases occurring in children under five years old. Its main pathological change is systemic vasculitis. The main symptoms include fever, congested and cracked lips, diffuse congestion of the oral mucosa, swollen tongue papillae, and strawberry tongue. Other symptoms may include swelling of the hands and feet, polymorphous erythema, and enlarged lymph nodes. There could be subsequent cardiac complications, primarily affecting the coronary arteries. Kawasaki disease may cause vomiting due to the diffuse congestion in the oral cavity, and the pharynx might also be congested. When children experience significant congestion, their laryngeal reflex might be sensitive, possibly leading to vomiting. Furthermore, children with Kawasaki disease might develop secondary infections from other bacteria and viruses, which could also lead to symptoms like vomiting. Therefore, the manifestations of Kawasaki disease can vary, and if significant vomiting occurs, it should be investigated to determine the cause.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
46sec home-news-image

What should be paid attention to in the diet for Kawasaki disease?

Kawasaki disease is a type of mucocutaneous lymph node syndrome, and its main pathological change is systemic vasculitis. Its main characteristics include persistent fever, high fever, ineffective antibiotic treatment, followed by the appearance of a skin rash on the mucous membranes, accompanied by enlarged lymph nodes. When Kawasaki disease occurs, there is a high fever, so it is suggested that children with Kawasaki disease should consume a diet high in protein, calories, and fiber, which is light and easily digestible in liquid or semi-liquid form. Spicy, overly hard, and overly hot foods should be avoided.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
54sec home-news-image

Does Kawasaki disease affect lifespan?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has an unclear pathogenesis. Its pathological changes primarily involve a systemic circulatory disease characterized by vasculitis. A severe complication can lead to cardiac lesions. Generally, Kawasaki disease is self-limiting and most cases have a good prognosis. However, if Kawasaki disease is not effectively treated and results in associated coronary artery aneurysms or large artery aneurysms, it could lead to acquired heart disease. Such cardiac issues could potentially affect cardiac function later on. This might impact lifespan, but if Kawasaki disease is treated aggressively and effectively, the prognosis is good and the impact on future health is minimal.

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
52sec home-news-image

Is Kawasaki disease characterized by eye discharge?

Kawasaki disease is an autoimmune vasculitis that can affect blood vessels throughout the body and various organs, but the most severe impact is typically on the coronary arteries, which can lead to dilation of the coronary arteries or the possibility of forming coronary artery aneurysms. The disease can cause conjunctival congestion, but this is a manifestation of aseptic conjunctivitis, meaning it does not cause, nor does it result in, purulent secretions, in other words, it does not cause eye discharge. Therefore, if a patient with Kawasaki disease has purulent eye discharge, it is possible that they have a concurrent bacterial conjunctivitis. Thus, generally, eyes affected by Kawasaki disease do not have eye discharge but may appear dry and red.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
42sec home-news-image

How long to take aspirin for Kawasaki disease

The current pathogenesis of Kawasaki disease is not yet clear, but one of its main pathological changes is a systemic vasculitis. During an outbreak of Kawasaki disease, the blood viscosity increases primarily due to platelet aggregation. Typically, oral aspirin is administered to prevent this inflammation and to treat platelet aggregation. The dosage is generally reduced gradually once the fever subsides, with maintenance doses lasting about six to eight weeks. If coronary artery lesions are present, the duration of medication is extended until the coronary arteries return to normal before discontinuing the drug.

doctor image
home-news-image
Written by Yao Li Qin
Pediatrics
1min 16sec home-news-image

How is Kawasaki disease treated?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, can cause damage to the coronary arteries in untreated children, so it is crucial to treat the disease promptly once diagnosed. This disease generally occurs sporadically or in small outbreaks and can occur in any season, predominantly affecting infants and young children. The main treatment for Kawasaki disease is aspirin, which not only reduces fever but also helps reduce coronary artery lesions. Additionally, intravenous immunoglobulin is administered; however, the use of corticosteroids in Kawasaki disease is still somewhat controversial. Other treatments mainly include antiplatelet aggregation agents such as dipyridamole, and symptomatic supportive care for the child, including fluid supplementation, heart protection, control of heart failure, and correction of arrhythmias. For severe coronary artery lesions, coronary artery bypass surgery may be required. (Please use medication under the guidance of a professional physician.)